Loading...
XASX
ADO
Market cap68mUSD
Jun 23, Last price  
0.03AUD
1D
-3.33%
1Q
190.00%
Jan 2017
-25.98%
IPO
-99.02%
Name

Anteotech Ltd

Chart & Performance

D1W1MN
XASX:ADO chart
P/E
P/S
97.57
EPS
Div Yield, %
Shrs. gr., 5y
11.27%
Rev. gr., 5y
26.47%
Revenues
969k
+110.44%
809,60491,14181,114226,312265,75211,846146,700219,567309,759468,782724,4782,472,000236,427150,243299,403898,067760,875365,724460,397968,878
Net income
-7m
L-23.89%
-6,245,000-1,563,000-1,762,000-1,949,000-2,255,000-2,222,000-2,380,000-2,179,000-2,492,000-4,221,000-5,956,000-10,527,000-3,636,000-3,297,000-3,127,000-6,216,000-10,717,000-12,654,000-8,881,000-6,759,135
CFO
-6m
L-10.65%
-2,408,836-981,555-1,453,153-1,936,120-2,150,231-2,099,121-1,928,677-2,270,754-1,976,666-3,366,231-7,159,295-340,669-4,512,184-2,343,530-2,501,902-4,549,298-8,653,389-8,083,171-6,520,976-5,826,189

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

AnteoTech Limited develops, manufactures, commercializes, and distributes products for clean energy technology and life science markets primarily in Australia, Asia, Europe, and North America. The company’s products include AnteoBind, a metal-ion complex-based activation technology that offers an alternative to conventionally used chemistries for the life sciences industry; AnteoBind NXT solution for the development of diagnostic tests; AnteoBind Micro and Micro Kit, a micro-particle-based assay development and bioseparation; AnteoBind Sub-Micron, Particle-based assay development, and bioseparation; AnteoBind Biosensor, a planar solid phase assay development; Activation Kit Multiplex Microspheres, an immunoassay development; and Nano Kit, a nanoparticle-based lateral flow assay development and bioseparation. It also provides AnteoX, an additive that reinforces battery binders that enhance performance of silicon containing anodes; and Ultranode, an ultra-high silicon anode design to offer high performance for lithium-ion batteries. In addition, the company offers contract services. The company was formerly known as Anteo Diagnostics Limited and changed its name to AnteoTech Limited in November 2019. AnteoTech Limited is headquartered in Eight Mile Plains, Australia.
IPO date
Apr 11, 2000
Employees
24
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑062024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT